Oncology R&D: emerging therapies and new challenges
The oncology market, already huge, is set for major expansion. According to analysis from GlobalData, it will generate trillions of…
The oncology market, already huge, is set for major expansion. According to analysis from GlobalData, it will generate trillions of…
With the world facing threats from new and emerging infectious diseases, the ability to rapidly ramp up production of essential…
As smaller, leaner organisations that must utilise resources carefully, biotechs face unique challenges as they enter clinical trials. These challenges…
Climate change’s escalating impact is reshaping the infectious disease landscape in pervasive and profound ways. Rising temperatures are expanding the…
Recent research from GlobalData analyzed the Net Zero strategies of the world’s top 18 pharmaceutical companies by revenue. All of…
The pharmaceutical industry is on the brink of a remarkable transformation over the next ten years. As the demand for…
Pharmaceutical supply chains are some of the world’s most intricate. Recent developments have only heightened the challenges for companies on…
Managing chronic myeloid leukemia (CML) can be challenging, especially when it comes to accurately tracking how well patients respond to…
Disruption is a pressing problem in the pharmaceutical world; patient health depends on the smooth and predictable movement of resources…
Cancer, once primarily perceived as a disease of the elderly, is now becoming a major concern for young adults. The…